<?xml version='1.0' encoding='utf-8'?>

<rss version="2.0">
  <channel>
    <title>The Federal Register</title>
    <link>http://thefederalregister.com/b.p/department/DEPARTMENT_OF_HEALTH_AND_HUMAN_SERVICES/2003-05-28/</link>
    <description>Daily Publications of Meetings and Rules Changes for the Federal Government</description>
    <pubDate>Tue, May 21 2013 11:00:00 GMT</pubDate>
    <lastBuildDate>Tue, May 21 2013 11:00:00 GMT</lastBuildDate>
    <webMaster>info@thefederalregister.com</webMaster>
    <item>
  <title><![CDATA[  Addressing Asthma From a Public Health Perspective; Notice of  Availability of Funds]]></title>
  <link>http://thefederalregister.com/d.p/2003-05-28-03-13222</link>
  <description><![CDATA[ </p><p>    Application Deadline: July 14, 2003.<br/>
A. Authority and Catalog of Federal Domestic Assistance Number
</p><p>    This program is authorized under section 301 and 317 of the Public 
Health Service Act [42 U.S.C. section 241 and 247b], as amended. The  Catalog of Federal Domestic Assistance number is 93.283.</p>
<h3>B. Purpose</h3>
<p>    The Centers for Disease Control and Prevention (CDC) announces the 
availability of fiscal year (FY) 2003 funds for a cooperative agreement 
program for ``Addressing Asthma from a Public Health Perspective.'' 
This program addresses the ``Healthy People 2010'' focus areas 
Environmental Health, Occupational Safety and Health, and Respiratory  Diseases.</p><p>    The purpose of the program is to provide the impetus to begin 
development of program capacity to address asthma from a public health 
perspective in order to bring about: (1) A focus of asthmarelated 
activity within the agency; (2) an increased understanding of asthma
related data and its application to program planning through 
development o<script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2003-05-28-03-13222</guid>
  <pubDate>Wed, May 28 2003 11:00:00 GMT</pubDate>
</item>
<item>
  <title><![CDATA[  Requirements for Liquid Medicated Animal Feed and Free-Choice  Medicated Animal Feed]]></title>
  <link>http://thefederalregister.com/d.p/2003-05-28-03-12974</link>
  <description><![CDATA[ The Food and Drug Administration (FDA) is proposing to change 
the regulations for liquid medicated feed and freechoice medicated 
feed. By changing the regulations for liquid medicated feed, FDA wants 
to clarify: What data are required to demonstrate chemical and physical 
stability of a drug in liquid feed; how such data may be submitted for 
use in the new animal drug approval process; and which liquid medicated 
feeds may be manufactured in a feed manufacturing facility that has not 
obtained a medicated feed mill license from FDA. By changing the 
regulations for freechoice medicated feed, FDA wants to ensure that 
they are consistent with the requirements for liquid medicated feed, 
and that provisions for freechoice medicated feed and liquid medicated 
feed comply with the terms of the Animal Drug Availability Act (ADAA) 
of 1996.
<script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2003-05-28-03-12974</guid>
  <pubDate>Wed, May 28 2003 11:00:00 GMT</pubDate>
</item>
<item>
  <title><![CDATA[  Determination That Periactin Was Not Withdrawn From Sale for  Reasons of Safety or Effectiveness]]></title>
  <link>http://thefederalregister.com/d.p/2003-05-28-03-13193</link>
  <description><![CDATA[ The Food and Drug Administration (FDA) has determined that 
Periactin (cyproheptadine hydrochloride (HCl)) 4milligram (mg) tablets 
were not withdrawn from sale for reasons of safety or effectiveness. 
This determination will allow FDA to approve abbreviated new drug 
applications (ANDAs) for cyproheptadine HCl 4mg tablets.
<script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2003-05-28-03-13193</guid>
  <pubDate>Wed, May 28 2003 11:00:00 GMT</pubDate>
</item>
<item>
  <title><![CDATA[  FDA/Industry Exchange Workshop on FDA Clinical Trials Statutory  and Regulatory Requirements; Public Workshop]]></title>
  <link>http://thefederalregister.com/d.p/2003-05-28-03-13192</link>
  <description><![CDATA[ The Food and Drug Administration (FDA) Philadelphia District, 
in cooperation with the Society of Clinical Research Associates, 
(SoCRA) is announcing a workshop on FDA clinical trial statutory and 
regulatory requirements. Topics for discussion include: Financial 
incentives and funding, preIND (investigational new drug application) 
meetings and FDA meeting process, medical device aspects of clinical 
research, informed consent requirements, adverse event reporting, how 
FDA conducts bioresearch inspections, ethics in clinical research, FDA 
and confidence in the conduct of clinical research, and how FDA 
addresses fraud in clinical research. This 2day workshop for the 
clinical research community targets sponsors, monitors, clinical 
investigators, institutional review boards and those who interact with 
them for the purpose of conducting FDA regulated clinical research. The 
workshop will include both industry and FDA perspectives on proper  conduct of clinical trials regulated by FDA.</p><p>    Date and Time:<script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2003-05-28-03-13192</guid>
  <pubDate>Wed, May 28 2003 11:00:00 GMT</pubDate>
</item>
<item>
  <title><![CDATA[  Agency Information Collection Activities: Proposed Collection:  Comment Request]]></title>
  <link>http://thefederalregister.com/d.p/2003-05-28-03-13224</link>
  <description><![CDATA[
</p><p>    In compliance with the requirement for opportunity for public 
comment on proposed data collection projects (section 3506(c)(2)(A) of 
Title 44, United States Code, as amended by the Paperwork Reduction Act 
of 1995, Public Law 10413), the Health Resources and Services 
Administration (HRSA) publishes periodic summaries of proposed projects 
being developed for submission to OMB under the Paperwork Reduction Act 
of 1995. To request more information on the proposed project or to 
obtain a copy of the data collection plans and draft instruments, call  the HRSA Reports Clearance Officer on (301) 4431129.</p><p>    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected;<script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2003-05-28-03-13224</guid>
  <pubDate>Wed, May 28 2003 11:00:00 GMT</pubDate>
</item>
<item>
  <title><![CDATA[  Availability of Funds ]]></title>
  <link>http://thefederalregister.com/d.p/2003-05-28-03-13226</link>
  <description><![CDATA[ This notice extends the deadline for fiscal year 2003 
applications for Chiropractic Demonstration Project (CHIRO) Grants 
(Sec. 755(b)(3) of the Public Health Service Act) and expands the 
purpose of the Program. An August 9, 2002 Federal Register notice in 
the HRSA Preview (67 FR 52049) announced that the deadline for 
applications for the Chiropractic Demonstration Projects Program was 
March 31, 2003 and that the purpose of the Chiropractic Demonstration 
Projects Program is to carry out demonstration projects in which 
chiropractors and physicians collaborate to identify and provide 
effective treatment for spinal and lowerback conditions. The FY 2003 
Appropriations Act, Public Law 1087, expanded the purpose of the 
program to add funding for training components. Therefore, the deadline 
for applications is extended to June 20, 2003. Please mail applications 
to HRSA Grants Application Center, 901 Russell Avenue, Suite 450, 
Gaithersburg, Maryland 20857, postmarked no later than June 20, 2003.
<script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2003-05-28-03-13226</guid>
  <pubDate>Wed, May 28 2003 11:00:00 GMT</pubDate>
</item>
<item>
  <title><![CDATA[  HRSA-03-101 Fiscal Year 2003 Competitive Application Cycle for  the Comprehensive Geriatrics Education Program (CGEP)]]></title>
  <link>http://thefederalregister.com/d.p/2003-05-28-03-13225</link>
  <description><![CDATA[ The Health Resources and Services Administration (HRSA) 
announces that applications will be accepted for the Comprehensive  Geriatrics Education Program for Fiscal Year 2003.</p><p>    Authorizing legislation: These applications are solicited under the 
authority of Title VIII, Section 855 of the Public Health Service (PHS)  Act, as amended.</p><p>    Purpose: Grants will be awarded to eligible entities for programs 
thatProvide training to individuals who will provide geriatric care 
for the elderly by enhancing the knowledge, skills, and leadership 
potential of registered nurses (RN) providing care to older adults in a 
variety of settings. Projects must demonstrate that the preparation of 
RNs benefits licensed practical nurses (LPN) and certified nurse 
assistants (CNA). Each project must describe the program for RNs and 
the specific activities designed to develop and strengthen the skills 
of LPNs and CNAs to promote quality care for the geriatric population.
</p><p>    Statutory matching or cost sharing requirement: N<script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2003-05-28-03-13225</guid>
  <pubDate>Wed, May 28 2003 11:00:00 GMT</pubDate>
</item>
</channel>
</rss>

